Yu Peng

1.3k total citations
50 papers, 962 citations indexed

About

Yu Peng is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Yu Peng has authored 50 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Yu Peng's work include Liver physiology and pathology (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and RNA modifications and cancer (6 papers). Yu Peng is often cited by papers focused on Liver physiology and pathology (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and RNA modifications and cancer (6 papers). Yu Peng collaborates with scholars based in China, Canada and United States. Yu Peng's co-authors include Lielian Zuo, Nan Zhang, Lijian Tao, Zedong Li, Huixiang Yang, Jun Zhou, Xin Shen, Hanmin Li, Zhangzhe Peng and Liping Jiang and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Yu Peng

42 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Peng China	19	519	242	165	119	113	50	962
Xiaoyan Wu China	23	532 1.0×	146 0.6×	212 1.3×	107 0.9×	106 0.9×	47	1.1k
Shang‐Lun Chiang Taiwan	19	404 0.8×	233 1.0×	125 0.8×	135 1.1×	72 0.6×	31	975
Runchen Miao China	21	689 1.3×	602 2.5×	187 1.1×	184 1.5×	141 1.2×	37	1.1k
Ming Su China	15	381 0.7×	194 0.8×	320 1.9×	76 0.6×	150 1.3×	54	912
Yidong Yang China	18	635 1.2×	483 2.0×	236 1.4×	126 1.1×	110 1.0×	45	1.2k
Fanping Meng China	16	258 0.5×	146 0.6×	185 1.1×	82 0.7×	173 1.5×	38	748
Ute Haas Germany	19	398 0.8×	132 0.5×	380 2.3×	106 0.9×	310 2.7×	36	1.1k
Weilong Hong China	20	564 1.1×	194 0.8×	94 0.6×	150 1.3×	27 0.2×	36	997
Yongtao Xiao China	21	490 0.9×	225 0.9×	279 1.7×	220 1.8×	205 1.8×	61	1.3k

Countries citing papers authored by Yu Peng

Since Specialization

Citations

This map shows the geographic impact of Yu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Peng more than expected).

Fields of papers citing papers by Yu Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Peng. The network helps show where Yu Peng may publish in the future.

Co-authorship network of co-authors of Yu Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Peng. A scholar is included among the top collaborators of Yu Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Peng. Yu Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Shenglan, Wei Wu, Damu Tang, et al.. (2025). Peroxiredoxin 1 promotes intestinal inflammation by activating the NLRP3 inflammasome in macrophages through lysosomal disruption in Crohn’s disease. Cell Death and Disease. 16(1). 565–565.

Song, Xiaoyue, et al.. (2025). Cardiomyocyte GSDME Drives Doxorubicin-Induced Cardiotoxicity by Targeting the CCL2-CCR2 Axis. International Journal of Biological Sciences. 21(14). 6113–6131.

Wang, Jinjin, Futao Liu, Cai Zhao, et al.. (2024). G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis. Biochemical Pharmacology. 222. 116077–116077. 9 indexed citations

Chen, Dong, et al.. (2024). Unlocking survival benefits: primary tumor resection in de novo stage IV breast cancer patients. Expert Review of Anticancer Therapy. 24(12). 1303–1310. 1 indexed citations

Jiang, Shang I. Brian, Yu Peng, Lin Zhang, et al.. (2024). Current status and development trends of research on collaborative control methods for unmanned cluster. IET conference proceedings.. 2024(20). 296–302.

Zhang, Rong, et al.. (2023). circ_SIRT1 upregulates ATG12 to facilitate Imatinib resistance in CML through interacting with EIF4A3. Gene. 893. 147917–147917. 4 indexed citations

He, Qingqing, Yu Peng, Li Liu, et al.. (2023). Untargeted metabolomics analysis of plasma metabolic characteristics in patients with acne and insulin resistance. Amino Acids. 55(10). 1417–1428. 4 indexed citations

Tang, Qin, Xiang Tang, Yan Liu, et al.. (2023). Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo. Journal of Ethnopharmacology. 314. 116618–116618. 21 indexed citations

Peng, Yu, et al.. (2023). Progress and Clinical Applications of Crohn’s Disease Exclusion Diet in Crohn’s Disease. Gut and Liver. 18(3). 404–413. 2 indexed citations

10.

Lai, Chyong‐Huey, et al.. (2023). Gastrointestinal: A case of IgG4‐related disease involving intestinal tract and orbital cavity. Journal of Gastroenterology and Hepatology. 38(11). 1865–1865.

11.

Gu, Lei, Shenglan Li, Jie Tang, et al.. (2023). Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway. Biomedicine & Pharmacotherapy. 164. 114844–114844. 15 indexed citations

12.

Lu, Feng, et al.. (2023). Application of a three-dimensional printed pelvic model in laparoscopic radical resection of rectal cancer. Frontiers in Oncology. 13. 1195404–1195404. 4 indexed citations

13.

Zhang, Qian, Yuna Huang, Kui Lu, et al.. (2023). Synthesis and mechanism of action of new purine derivatives against triple negative breast cancer. European Journal of Medicinal Chemistry. 261. 115797–115797. 1 indexed citations

14.

Zhou, Nan, et al.. (2021). A random forest model predicts responses to infliximab in Crohn’s disease based on clinical and serological parameters. Scandinavian Journal of Gastroenterology. 56(9). 1030–1039. 15 indexed citations

15.

Qin, Jiao, Zhangzhe Peng, Qiongjing Yuan, et al.. (2019). AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways. Scientific Reports. 9(1). 4407–4407. 34 indexed citations

16.

Shen, Xin, Yu Peng, & Hanmin Li. (2017). The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis. Frontiers in Immunology. 8. 1450–1450. 36 indexed citations

17.

Xiao, Yun, Yu Peng, Ling Huang, et al.. (2016). GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression. PLoS ONE. 11(9). e0160855–e0160855. 21 indexed citations

18.

Huang, Ling, Fangfang Zhang, Yiting Tang, et al.. (2014). Fluorofenidone Attenuates Inflammation by Inhibiting the NF-κB Pathway. The American Journal of the Medical Sciences. 348(1). 75–80. 10 indexed citations

19.

Mei, Wenjuan, Yanyun Xie, Jishi Liu, et al.. (2014). Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways. PLoS ONE. 9(10). e111242–e111242. 10 indexed citations

20.

Huang, Ling, Yiting Tang, Yu Peng, et al.. (2011). Vasoactive Intestinal Peptide Enhances TNF-α-Induced IL-6 and IL-8 Synthesis in Human Proximal Renal Tubular Epithelial Cells by NF-κB-Dependent Mechanism. Inflammation. 35(3). 1154–1160. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact